glp 1 receptor agonists names brand Understanding GLP-1 Agonists: Key Insights for Payers Evolution of GLP‐1 Receptor Agonists
Description
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
doi: 10.2337/dc08-1309
They can be used in conjunction with other anti-diabetic drugs, such as SGLT-2 inhibitors [7]
Additionally, excluding patients with a diagnosis of any psychiatric diseases within one year before or one month after the index date may not be sufficient to avoid bias
34 There are currently 3 SGLT-2 inhibitors available in the U.S.: canagliflozin (Invokana), dapagliflozin (Farxiga), and empagliflozin (Jardiance)
